These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 11238126
1. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling. Morgan MA, Dolp O, Reuter CW. Blood; 2001 Mar 15; 97(6):1823-34. PubMed ID: 11238126 [Abstract] [Full Text] [Related]
2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Miranda MB, McGuire TF, Johnson DE. Leukemia; 2002 Apr 15; 16(4):683-92. PubMed ID: 11960350 [Abstract] [Full Text] [Related]
3. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P, Grant S. Cancer Res; 2002 Jan 01; 62(1):188-99. PubMed ID: 11782377 [Abstract] [Full Text] [Related]
4. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. Clark SS, Zhong L, Filiault D, Perman S, Ren Z, Gould M, Yang X. Clin Cancer Res; 2003 Oct 01; 9(12):4494-504. PubMed ID: 14555523 [Abstract] [Full Text] [Related]
5. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Zhang J, Lodish HF. Blood; 2004 Sep 15; 104(6):1679-87. PubMed ID: 15166036 [Abstract] [Full Text] [Related]
6. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. Okano J, Rustgi AK. J Biol Chem; 2001 Jun 01; 276(22):19555-64. PubMed ID: 11278851 [Abstract] [Full Text] [Related]
7. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Stadheim TA, Xiao H, Eastman A. Cancer Res; 2001 Feb 15; 61(4):1533-40. PubMed ID: 11245462 [Abstract] [Full Text] [Related]
8. Coadministration of UCN-01 with MEK1/2 inhibitors potently induces apoptosis in BCR/ABL+ leukemia cells sensitive and resistant to ST1571. Yu C, Dai Y, Dent P, Grant S. Cancer Biol Ther; 2002 Feb 15; 1(6):674-82. PubMed ID: 12642693 [Abstract] [Full Text] [Related]
9. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras. Brassard DL, English JM, Malkowski M, Kirschmeier P, Nagabhushan TL, Bishop WR. Exp Cell Res; 2002 Feb 15; 273(2):138-46. PubMed ID: 11822869 [Abstract] [Full Text] [Related]
10. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE. Oncogene; 2002 Nov 21; 21(53):8075-88. PubMed ID: 12444544 [Abstract] [Full Text] [Related]
11. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Park JI, Strock CJ, Ball DW, Nelkin BD. Mol Cell Biol; 2003 Jan 21; 23(2):543-54. PubMed ID: 12509453 [Abstract] [Full Text] [Related]
12. Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism. Dai Y, Landowski TH, Rosen ST, Dent P, Grant S. Blood; 2002 Nov 01; 100(9):3333-43. PubMed ID: 12384435 [Abstract] [Full Text] [Related]
13. Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways. Yu C, Subler M, Rahmani M, Reese E, Krystal G, Conrad D, Dent P, Grant S. Cancer Biol Ther; 2003 Nov 01; 2(5):544-51. PubMed ID: 14614324 [Abstract] [Full Text] [Related]
14. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK, McCubrey JA. Leukemia; 2003 Jun 01; 17(6):1058-67. PubMed ID: 12764369 [Abstract] [Full Text] [Related]
15. The 96 kDa protein kinase activated by oncogenic Ras in Xenopus egg extracts is also activated by constitutively active Mek: activation requires serine/threonine phosphorylation. Pan BT, Zhang Y, Brott B, Chen DH. Oncogene; 1997 Apr 10; 14(14):1653-60. PubMed ID: 9135066 [Abstract] [Full Text] [Related]
16. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Kamiguti AS, Harris RJ, Slupsky JR, Baker PK, Cawley JC, Zuzel M. Oncogene; 2003 Apr 17; 22(15):2272-84. PubMed ID: 12700663 [Abstract] [Full Text] [Related]
17. Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth. Kapoor GS, Atkins BA, Mehta KD. Mol Cell Biochem; 2002 Jul 17; 236(1-2):13-22. PubMed ID: 12190111 [Abstract] [Full Text] [Related]
18. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Plattner R, Gupta S, Khosravi-Far R, Sato KY, Perucho M, Der CJ, Stanbridge EJ. Oncogene; 1999 Mar 11; 18(10):1807-17. PubMed ID: 10086335 [Abstract] [Full Text] [Related]
19. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N. Blood; 2001 Sep 01; 98(5):1429-39. PubMed ID: 11520792 [Abstract] [Full Text] [Related]
20. Importance of MEK in neutrophil microbicidal responsiveness. Downey GP, Butler JR, Tapper H, Fialkow L, Saltiel AR, Rubin BB, Grinstein S. J Immunol; 1998 Jan 01; 160(1):434-43. PubMed ID: 9552001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]